Vaccine Scheduler
Netherlands: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 3 | 5 | 12 | 14 | 4 | 5 | 9 | 10 | 14 | 18 | ||||
| Coronavirus disease (COVID-19)1 | COVID-193 | |||||||||||||
| tuberculosis | BCG4 | |||||||||||||
| rotavirus infection | ROTA | ROTA | ||||||||||||
| diphtheria | D | D | D | D | D | D | d5 | |||||||
| tetanus | TT | TT | TT | TT | TT | TT | TT5 | |||||||
| pertussis | acP6 | acP | acP | acP | acP | acp5 | ||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | IPV | IPV | ||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | Hib | ||||||||||
| hepatitis B | HepB7 | HepB | HepB | HepB | HepB | |||||||||
| pneumococcal disease2 | PCV10 | PCV10 | PCV10 | |||||||||||
| meningococcal disease | MCV48 | MCV48 | ||||||||||||
| measles | MEAS | MEAS | ||||||||||||
| mumps | MUMPS | MUMPS | ||||||||||||
| rubella | RUBE | RUBE | ||||||||||||
| human papillomavirus infection | HPV (F/M)9 | |||||||||||||
Version:
Footnotes:
- https://www.gezondheidsraad.nl/documenten/adviezen/2020/11/19/strategieen-voor-covid-19-vaccinatie
- More information available at https://www.rivm.nl/en/pneumococci/information-for-policy-makers
- https://www.rivm.nl/covid-19-vaccinatie
- vaccines only given on specific indications. please refer to https://www.kncvtbc.org/uploaded/2019/06/Handboek-Tuberculose-Nederland-2019-def.pdf for specific indications
- Recommended for pregnant women from 22 weeks gestation
- In the Netherlands, two primary doses (at 3 and 5 months) are provided for infants born from mothers who were vaccinated during pregnancy (at 22 weeks gestation). An additional vaccination is given at 2 months if the mother is not vaccinated during pregnancy.
- Offered to infants born to a mother infected with hepatitis B
- More information available at https://rijksvaccinatieprogramma.nl/vaccinaties/menacwy
- Two dose schedule at 0 and 6 months. Gender neutral (boys and girls) vaccination.
More information available at:
https://rijksvaccinatieprogramma.nl/vaccinaties/vaccinatieschema
----------------------------------------------------------------------------------------------
More information on vaccination available from:
Ministry of Health http://www.rijksoverheid.nl/onderwerpen/vaccinaties
RIVM http://www.rivm.nl/Onderwerpen/Onderwerpen/R/Rijksvaccinatieprogramma
The National Immunisation Programme in the Netherlands: https://rijksvaccinatieprogramma.nl/english
----------------------------------------------------------------------------------------------
MAJOR HISTORICAL CHANGES
2002 (September): MenC vaccination was introduced, with a catch-up campaign for all 14 months-18 years.
2003 (March): Hib was added to DTwP and IPV in a combined vaccine at 2, 3, 4 and 11 months.
2003 (March): HepB vaccination was introduced for children of parents from a hepatitis B endemic area.
2005 (January): Accellular pertussis replaced whole-cell pertussis at 2, 3, 4 and 11 months.
2006 (January): A birth dose of HepB was introduced for children born to mothers infected with hepatitis B.
2006 (June): Pneumococcal vaccination was introduced at 2, 3, 4 and 11 months.
2009 (September): HPV vaccination was introduced for girls only with three doses (0, +1 and +6 months), starting with birth cohort 1997 (additional catch-up campaign for birth cohorts 1993-1996)
2011 (May): Pneumococcal vaccination changed from 7-valent to 10-valent vaccine (for children born from 1-3-2011)
2011 (October): Transition to universal HepB vaccination (for children born from 1-8-2011), given in a combined vaccine with DTaP, IPV and Hib
2013 (November): Change to pneumococcal recommendation: 2+1 schedule instead of 3+1 schedule
2014 (January): Change to HPV recommendation. For girls under age 15, Cervarix can be adminsitered in a 2 dose schedule instead of 3 previously.
The 0-1-6-schedule in under 15's is replaced by two doses in a 0-6-schedule.
Further information for those that are currently completing HPV vaccination is available from www.prikkenteller.nl
2018: May 2018, MenC vaccination at 14 months of age has been replaced by MenACWY. From October 2018, 13-14 year olds (in the year they turn 14 years) have been vaccinated with MenACWY vaccination. A catch-up campaign was conducted in 2018-2019 targeting 14-18 year olds.
From 2021: HPV vaccination will be extended to boys
2022: HPV as a 2-dose schedule at 15 years of age (2 doses 6 months apart)
2024: introduction of Rota vaccination for those born from 1 Jan. 2024
2024: 11 months DTapIPV-Hib-HepB dose changed to 12 monts
----------------------------------------------------------------------------------------------
Date of last update: 25 Jan. 2024
----------------------------------------------------------------------------------------------